$FUSZ: S.H.A.C SUMMARY 04/30/18 Rory is killing

New Post Public Reply Private Reply Replies (2) Message Board
SHEEPWOLF
452
$FUSZ: S.H.A.C SUMMARY 04/30/18 Rory is killing it....
LINK: https://nfusz.com/super/ajax/ajax2.php?mediaid=iWV4eA
SUMMARY:
1. No gag order on T.A.
2. O/S=158M
3. Float=56,715,250
4. Oceanside isn't selling any shares
5. Kodiak is a believer in the business and aren't selling
6. Naked shorting of the stock:
*Rory believes it's his job to protect investors
*Refuses to run and hide and make believe nothing is going on
*Rory is protecting his "friends", shareholders
*He has brought on a legal team (who are investors)that will take care of this naked short thing. They have a vested interest. They are experts.
*Rory is staying focussed on the business.
*OTC markets publish the Reg SHO List and show a significant fail to deliver
https://www.otcmarkets.com/market-activity/reg-sho-data
naked shorting: shorting shares that do not exist

The MMs have not conducted themselves according to the rules, they have not abided by the settlement date rules
THEY HAVE NOT COVERED BY THE SETTLEMENT DATE>>>>>ILLEGAL NAKED SHORTING

ANSWER: JOE DAVIS AND THE LEGAL TEAM IS WORKING ON THE NAKED SHORTING ISSUE AND THE MMs WILL NEED TO COVER SOON.

http://arc4adr.com/joseph_a_davis.php
7. OUR INTEREST IS ALIGNED WITH THE INSIDERS 100%
8. Contact your broker and let them know that you don't want your shares borrowed. Set a high sell order on your shares to prevent them from being borrowed.
9. Don't allow yourself to be scared by false information (FUD) being spread
10. Valuation: not based on current earnings. Valuation is not based on cash - liabilities (liquidation value)
Valuation is based upon a multiple of anticipated future earnings, encouraged to do research.
There are companies with billion dollar valuations that have zero revenue and zero earnings. FB, TWTR, GOOG, PINTEREST for years no revenue
11. PE ratio for companies in CRM space (cloud based, monthly recurring revenue through subscriptions), i.e. Salesforce PE ratio according to MorningStar is 707.2, the average for CRM 104.5.
Valuation
12. ORACLE DEAL IS DONE, ROCK SOLID see 8K, see also Oracle website
http://suiteapp.com/Interactive-Video-and-not...M-by-nFusz
8K:
http://www.otcmarkets.com/edgar/GetFilingHtml...D=12456078
DD: https://investorshangout.com/post/view?id=4995855

13. Super conservative estimate of valuation based on only 100K subs with Oracle $10/sub= $1M/month, $12M/year
*O/S=156M but for purpose of example let's use fully diluted SS of 200M shares>>>>earning/shares based on $12M/year revenue, approx..06
PE ratio=104.5x.06=$6.27

14. Stock is grossly undervalued according to Rory and the people on the team that are working mostly for shares.
15. Check out the technology, yes we have a contract with Oracle-Netsuite and Marketo, check it out, talk to other investors that went to SuiteWorld18 and Marketo Nation.
**nFUSZ has done tons of demos for investors and companies at the conference and they saw the reaction of people to the technology. Talk to investors, yet another piece of DD.
16. Why should we believe Rory? When the 1st version (beta) of the product was launched we needed projections for the people that loaned the company money. The testing proved that applications that you have to download was fading away and teh trend was towards cloud based applications. People/Companies don't want to download applications. nFUSZ is cloud based, you can use the platform anywhere on any device. Changing to a cloud based solution changed everything and took time. Cloud based application brought greater value to the company; we already have version 2.0 out there and integrated with Oracle.
17. Rich Bohn: goes into incredible depth on the technology, he's the foremost expert on CRM technology and he is coming out with the review, please be patient.
18. Shell Oil signed up for an enterprise account
19. School districts are signing up
20. Oracle Netsuite has come up with new ways they want to use the product internally
21. Capital raising: We are now fully funded and debt-free. We can go for a year or more without raising any funds. Trying to uplist as quickly as possible. An announcement will be coming soon about who has been engaged to help with the uplisting. BOD search is ongoing.
22. VALUE CREATION, WANTS SHARES WORTH AS MUCH AS POSSIBLE FOR SHAREHOLDERS AND INSIDERS
23. We are trying to get as many users on the platform as possible, giving free trials, there will be referrals. Look for Q2 and Q3 to show the revenues.
24. notifiID being used teh same way MSFT did with hotmail, give it away and when they want more features they will sign up. notiifiID is global!
25. sub numbers: we are pitching clients that have extremely large users bases (100s of thousands, some millions). Making subscriber base public creates a position of weakness for the company. Notice AMZN just published their subscription numbers after years and years in business, they held those numbers for good reason.
BE PATIENT
26. The company has never ever been in a stronger position than right now, the future has never looked brighter than right now. Rory, " I couldn't possibly be more excited about the company than I am right now."
27. Do your own DD, make informed decisions. Do not allow people to scare you out of your shares.
28. "We are killing it", "outperforming our own projections, our own plans."
29. There are things happening right now you won't know about for some time.
30. Our interest are totally aligned. Rory, "I have my own dough in this thing, think I want to throw that away? NO!"
31. We are here for you, you are our #1 concern.

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Outlook for the Packaging Robots Market to 2032

Updated Category News Views 128

The Expanding Landscape of Packaging Robots The Packaging Robots Market is on an exciting trajectory, projected to soar from an estimated USD 6.02 billion in 2023 to an impressive USD 16.67 billion by 2032. This remarkable growth is fueled by continuous technological advancements and the ever-increasing demand for automation, as businesses strive for greater efficiency in...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 88

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading
Join the Fight: Investors Urged to Act Against Flywire's Missteps

Updated Category News Views 180

Critical Insights into Flywire Corporation's Recent Challenges In light of recent events, investors in Flywire Corporation (NASDAQ: FLYW) are presented with a pivotal opportunity to address potential securities fraud claims. Allegations suggest that the company might have communicated misleading business information to the public, raising concerns among its shareholders....

Continue Reading
LEPAS L8: A Game-Changer for Electric Vehicle Enthusiasts

Updated Category News Views 308

LEPAS L8: Redefining the Future of NEVs The innovative leap forward in the world of electric vehicles comes with Chery Group's brand new energy vehicle (NEV) brand, LEPAS, and its latest offering, the L8 model. The introduction of the L8 marks a significant milestone for Chery as it establishes a new standard in driving sophistication. This model is poised to make waves...

Continue Reading
Integra LifeSciences Launches Pediatric Registry for AERA System

Updated Category News Views 128

Integra LifeSciences Initiates Pediatric AERA Registry Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA...

Continue Reading